Abstract
Bipolar I disorder (BPD-1) is a chronic mood disorder characterized by manic and depressive episodes that produces a substantial financial burden in the US. This retrospective chart review study compared healthcare resource utilization (HRU) among patients with depressive episodes associated with BPD-1 treated with lurasidone or cariprazine, two atypical antipsychotics approved for treatment of bipolar depression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
